Oncobit and ID Solutions Announce Strategic Partnership
Oncobit, a leading Swiss company in precision oncology, announces a strategic partnership with ID Solutions, a French company specializing in developing innovative diagnostic solutions in oncology. The goal of this collaboration...
VISCHER advises AFINUM on the acquisition of a majority stake in Ergon Informatik
VISCHER advises AFINUM on the acquisition of a majority stake in Ergon Informatik AG, a leading Swiss IT service provider with a focus on software development and digital security solutions.
The VISCHER team, led by Dr Jürg...
VISCHER advises AFINUM on the sale of Threema
AFINUM has entered into an agreement to sell Threema to Comitis Capital. Threema is a leading provider of highly secure digital communication solutions for enterprises and public institutions. The transaction is expected to close...
ASTRA Therapeutics Seed Round Closing
ASTRA Therapeutics SA, a start-up company developing precision drugs against eukaryotic pathogens, announced the successful closing of its CHF 7.75m seed financing round.
The investment was co-led by MIG Capital and Digitalis...
FoRx Therapeutics raises USD 50m in Series A Financing Round
FoRx Therapeutics AG, a clinical-stage biotechnology company developing precision anti-cancer therapeutics, closed a USD 50m Series A Financing Round with existing investors including EQT Life Sciences, Pfizer Ventures, Novartis...
RELIEF and NeuroX complete Business Combination to form MindMaze
MindMaze Therapeutics Holding SA (SIX:MMTX; previously: RELIEF THERAPEUTICS Holding SA) acquired all the shares of NeuroX Group SA against issuance of new MMTX shares to complete their business combination by way of reverse...
Aukera Therapeutics gibt Financing bekannt
Aukera Therapeutics, a preclinical-stage biotech spin-off from the University of Basel, recently announced that it has raised some CHF 4.5m to date and attracted new board member and investor David Urech. Other current investors...
Placement of USD 110 Million Financing of Oculis Holding AG
Oculis Holding AG (Nasdaq: OCS; XICE: OCS), a global biopharmaceutical company focused on breakthrough innovations to address significant unmet medical needs in ophthalmology and neuro-ophthalmology, announced the placements of...
RetinAI acquired by EssilorLuxottica
EssilorLuxottica, a global leader in vision care and eyewear, has acquired Ikerian AG, a health technology company operating under the RetinAI brand, specializing in AI and data management in eyecare.
VISCHER advises Family Trust on the sale of novia Group to Swedish Bufab Group
VISCHER advises Family Trust on the sale of novia Group, a provider of global sourcing solu-tions and engineering services operating across Germany, Switzerland, China, and Vietnam to the Swedish Bufab Group.